Gastrointestinal surgery
Conditions
Interventions
When FloTrac SVV >
10%, rapid fluid therapy (artificial colloid solution, Once 200ml)
When FloTrac SVV >
15%, rapid fluid therapy (artificial colloid solution, Once 200ml)
Sponsors
Shonan Kamakura General Hospital Department of Anesthesia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inpatients who undergo gastrointestinal surgery
Exclusion criteria
Exclusion criteria: 1) Patients with a history of myocardial infarction within 30 days prior to surgery 2) Patients with a history of percutaneous coronary intervention or coronary artery bypass surgery 3) Patients with unstable angina 4) Patients with decreased left ventricular function (LVEF<=50%) 5) Patients with a history of cerebrovascular disorder (excluding asymptomatic lacunar infarction) 6) Patients with a history of hospitalization due to heart failure within 30 days before surgery 7) Patients with severe liver disease (AST (GOT) or ALT (GPT)>=100 U) 8) Patients with severe kidney disease (BUN>25 mg / dL or serum creatinine>=2.0 mg / dL) 9) Patients with sepsis 10) Borben contraindicated patients 11) Women who may be pregnant or may become pregnant 12) A lactating woman 13) Patients with arrhythmia 14) In addition, patients whose research managers judged inappropriate based on medical evidence as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fluid responsiveness by administration of artificial colloid solution | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects associated with fluid therapy | — |
Countries
Japan
Contacts
Public ContactMisaki Ichikawa
Shonan Kamakura General Hospital Research Office
Outcome results
None listed